Rotate between your abdomen, upper thigh, and upper arm
Patients interested in GHK-Cu peptide therapy often seek support for: Results vary by patient and treatment protocol
Therapeutic Applications: Cellular Senescence: Age-related decline in cellular function and vitality DNA Damage Accumulation: Environmental and chronological genomic stress Mitochondrial Dysfunction: Impaired cellular energy production systems Metabolic Dysregulation: Altered cellular metabolism and repair processes Inflammatory Aging: Chronic low-grade inflammatory responses Oxidative Stress: Free radical damage and antioxidant system decline Cellular Optimization Mechanisms: NAD+ serves as a crucial cofactor in cellular energy metabolism, DNA repair processes, and gene expression regulation
Some users describe this as targeting the injection site while providing background benefits elsewhere
Injectable BPC-157 Standard dose range: 200500 mcg per day Administration: Subcutaneous injection, once daily or split into two doses Cycle length: Typically 412 weeks, followed by an assessment period Injection site: Abdominal subcutaneous tissue
For GHK-Cu discussions, the abdomen is usually the first site people mention because it is easier to keep spacing consistent